{"DataElement":{"publicId":"6423790","version":"1","preferredName":"Bile Duct Cancer Primary Risk Factor Name","preferredDefinition":"Text term to represent the name of the primary condition that increases a person's chance of developing a malignant tumor of the bile duct.","longName":"BDC_RISK_FACTOR","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6423689","version":"1","preferredName":"Bile Duct Carcinoma Primary Risk Factor","preferredDefinition":"A malignant tumor arising from the epithelium of the intrahepatic or extrahepatic bile duct.  Carcinomas that arise from the intrahepatic bile ducts and the hepatic ducts are called cholangiocarcinomas and are almost always adenocarcinomas.  Carcinomas that arise from the extrahepatic bile ducts are adenocarcinomas, adenosquamous carcinomas, squamous cell carcinomas, small cell carcinomas, or mucoepidermoid carcinomas._Occurring first in time or sequence; original; of greatest rank or importance or value._Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","longName":"6423683v1.0:6423687v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6423683","version":"1","preferredName":"Bile Duct Carcinoma","preferredDefinition":"A malignant tumor arising from the epithelium of the intrahepatic or extrahepatic bile duct.  Carcinomas that arise from the intrahepatic bile ducts and the hepatic ducts are called cholangiocarcinomas and are almost always adenocarcinomas.  Carcinomas that arise from the extrahepatic bile ducts are adenocarcinomas, adenosquamous carcinomas, squamous cell carcinomas, small cell carcinomas, or mucoepidermoid carcinomas.","longName":"C27814","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bile Duct Carcinoma","conceptCode":"C27814","definition":"A carcinoma arising from the intrahepatic or extrahepatic bile ducts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7512A3BE-2720-0C61-E053-F662850ADF1D","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-04","modifiedBy":"ONEDATA","dateModified":"2018-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6423687","version":"1","preferredName":"Primary Risk Factor","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.:Something that increases the chance of developing a disease. Some examples of risk factors for cancer are age, a family history of certain cancers, use of tobacco products, being exposed to radiation or certain chemicals, infection with certain viruses or bacteria, and certain genetic changes.","longName":"C25251:C17103","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk Factor","conceptCode":"C17103","definition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"750F598E-1B89-186A-E053-F662850AFF9E","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-04","modifiedBy":"ONEDATA","dateModified":"2018-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"750F598E-1B9A-186A-E053-F662850AFF9E","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-04","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer CDE request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3171838","version":"1.1","preferredName":"Primary Risk Factor Name","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary)_Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations._The words or language units by which a thing is known.","longName":"3171838v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Primary sclerosing cholangitis","valueDescription":"Primary Sclerosing Cholangitis","ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CFCF-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Crohn's disease","valueDescription":"Crohn Disease","ValueMeaning":{"publicId":"4618015","version":"1","preferredName":"Crohn Disease","longName":"4618015","preferredDefinition":"A chronic, transmural inflammation that can affect any location along the gastrointestinal tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crohn Disease","conceptCode":"C2965","definition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CF0E-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09CA817A-AB3A-6F9A-E050-BB89AD4314FF","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-09","modifiedBy":"ONEDATA","dateModified":"2014-12-09","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE57-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Alpha-1 Antitrypsin Deficiency","valueDescription":"Alpha-1 Antitrypsin Deficiency","ValueMeaning":{"publicId":"3171840","version":"1","preferredName":"Alpha-1 Antitrypsin Deficiency","longName":"3171840","preferredDefinition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-1 Antitrypsin Deficiency","conceptCode":"C84397","definition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0146-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE61-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Non-Alcoholic Fatty Liver Disease","valueDescription":"Nonalcoholic Fatty Liver Disease","ValueMeaning":{"publicId":"3171842","version":"1","preferredName":"Nonalcoholic Fatty Liver Disease","longName":"3171842","preferredDefinition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Fatty Liver Disease","conceptCode":"C84444","definition":"A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-016C-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE6B-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Hemochromatosis","valueDescription":"Hemochromatosis","ValueMeaning":{"publicId":"3171844","version":"1","preferredName":"Hemochromatosis","longName":"3171844","preferredDefinition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Hemochromatosis","conceptCode":"C84481","definition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0192-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE75-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Hepatitis C","valueDescription":"Hepatitis C","ValueMeaning":{"publicId":"2975596","version":"1","preferredName":"Hepatitis C","longName":"2975596","preferredDefinition":"An RNA virus, causes non-A and non-B Hepatitis and liver cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0F01-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE7F-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Hepatitis B","valueDescription":"Hepatitis B","ValueMeaning":{"publicId":"2946400","version":"1","preferredName":"Hepatitis B","longName":"2946400","preferredDefinition":"A viral hepatitis caused by the Hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7472988E-D1A5-00A0-E040-BB89AD433FCF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE89-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Alcohol consumption","valueDescription":"Alcohol Consumption","ValueMeaning":{"publicId":"3171845","version":"1","preferredName":"Alcohol Consumption","longName":"3171845","preferredDefinition":"The intoxicating beverage, ethanol.: The bodily process of taking in and using up something, especially the eating or drinking of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcohol","conceptCode":"C2190","definition":"A volatile liquid prepared by fermentation of certain carbohydrates. Alcohol acts as a central nervous system (CNS) depressant, a diuretic, and a disinfectant. Although the exact mechanism of CNS depression is unknown, alcohol may act by inhibiting the opening of calcium channels, mediated by the binding of the inhibitory neurotransmitter gamma-amino butyric acid (GABA) to GABA-A receptors, or through inhibitory actions at N-methyl-D-aspartate (NMDA)-type glutamate receptors. Alcohol inhibits the production of antidiuretic hormone, thereby producing diuresis that may lead to dehydration. This agent kills organisms by denaturing their proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Consumption","conceptCode":"C66715","definition":"The bodily process of taking in and using up something, especially the eating or drinking of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-01D8-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE93-8FD3-E050-BB89AD433831","beginDate":"2010-12-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"No History of Primary Risk Factors","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CE9D-8FD3-E050-BB89AD433831","beginDate":"2011-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CEAD-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Thorotrast contrast exposure","valueDescription":"Thorotrast Exposure","ValueMeaning":{"publicId":"4618012","version":"1","preferredName":"Thorotrast Exposure","longName":"4618012","preferredDefinition":"Exposure to thorotrast, which contains particles of the radioactive compound thorium dioxide, as a radiocontrast agent.  It is a carcinogenic compound, linked to the development of bile duct cancer, leukemia, and angiosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thorotrast Exposure","conceptCode":"C36187","definition":"Exposure to thorotrast, which contains particles of the radioactive compound thorium dioxide, as a radiocontrast agent. It is a carcinogenic compound, linked to the development of bile duct cancer, leukemia, and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CEBA-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CED3-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Liver fluke infestation","valueDescription":"Opisthorchis Viverrini Infection","ValueMeaning":{"publicId":"4618014","version":"1","preferredName":"Opisthorchis Viverrini Infection","longName":"4618014","preferredDefinition":"An infection caused by the parasite Opisthorchis viverrini. It results from the ingestion of raw or undercooked food. The clinical features vary from mild to severe and include gastrointestinal symptoms, anorexia, weight loss, hepatomegaly, and cholangitis. Patients are at an increased risk of developing cholangiocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Opisthorchis Viverrini Infection","conceptCode":"C39295","definition":"An infection caused by the parasite Opisthorchis viverrini. It results from the ingestion of raw or undercooked food. The clinical features vary from mild to severe and include gastrointestinal symptoms, anorexia, weight loss, hepatomegaly, and cholangitis. Patients are at an increased risk of developing cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CEE0-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CEF9-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Ulcerative colitis","valueDescription":"Ulcerative Colitis","ValueMeaning":{"publicId":"4264977","version":"1","preferredName":"Ulcerative Colitis","longName":"4264977","preferredDefinition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ulcerative Colitis","conceptCode":"C2952","definition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3D16-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CF03-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Smoking","valueDescription":"Smoking","ValueMeaning":{"publicId":"3187551","version":"1","preferredName":"Smoking","longName":"3187551","preferredDefinition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tobacco Smoking","conceptCode":"C17934","definition":"The act of puffing and/or inhaling smoke from a lit cigarette, cigar, or pipe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9ADB9901-7B34-C15B-E040-BB89AD43580B","latestVersionIndicator":"Yes","beginDate":"2011-01-27","endDate":null,"createdBy":"UMLLOADER_GEM","dateCreated":"2011-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CF31-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Hepatolithiasis","valueDescription":"Hepatolithiasis","ValueMeaning":{"publicId":"4618016","version":"1","preferredName":"Hepatolithiasis","longName":"4618016","preferredDefinition":"The presence of solitary or multiple stones in the intrahepatic bile ducts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatolithiasis","conceptCode":"C119011","definition":"The presence of solitary or multiple stones in the intrahepatic bile ducts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CF3C-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CF55-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Caroli disease (type V choledochal cyst)","valueDescription":"Caroli Disease","ValueMeaning":{"publicId":"3210935","version":"1","preferredName":"Caroli Disease","longName":"3210935","preferredDefinition":"A rare congenital disorder characterized by cystic dilatation of the intrahepatic bile ducts. It is associated with cholangitis and the formation of stones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Caroli Disease","conceptCode":"C84619","definition":"A rare congenital disorder characterized by cystic dilatation of the intrahepatic bile ducts. It is associated with cholangitis and the formation of stones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B6C2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CF69-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Choledochal cyst","valueDescription":"Choledochal Cyst","ValueMeaning":{"publicId":"4618017","version":"1","preferredName":"Choledochal Cyst","longName":"4618017","preferredDefinition":"Cystic dilatation of the hepatic duct or bile duct.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choledochal Cyst","conceptCode":"C2943","definition":"Cystic dilatation of the hepatic duct or bile duct.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CF74-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CF8D-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Diabetes mellitus","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CFA1-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09518164-CFC5-8FD3-E050-BB89AD433831","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"ONEDATA","dateModified":"2014-12-03","deletedIndicator":"No"},{"value":"Biliary parasites","valueDescription":"Biliary Parasite","ValueMeaning":{"publicId":"6423756","version":"1","preferredName":"Biliary Parasite","longName":"6423756","preferredDefinition":"A term that refers to the biliary tract structures.: An animal or plant that gets nutrients by living on or in an organism of another species. A complete parasite gets all of its nutrients from the host organism, but a semi-parasite gets only some of its nutrients from the host.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biliary","conceptCode":"C28011","definition":"A term that refers to the biliary tract structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Parasite","conceptCode":"C28176","definition":"Any organism that has a close, symbiotic relationship with a separate, host organism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520BE22-F231-0400-E053-F662850A776C","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520033E-D0D0-2151-E053-F662850A12D0","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Recurrent pyogenic cholangitis","valueDescription":"Recurrent pyogenic cholangitis","ValueMeaning":{"publicId":"6423755","version":"1","preferredName":"Recurrent pyogenic cholangitis","longName":"6423755","preferredDefinition":"The return of a disease after a period of remission.: Cholangitis that is characterized by pyogenic organisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Suppurative Cholangitis","conceptCode":"C35336","definition":"Cholangitis that is characterized by pyogenic organisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520BE22-F1CB-0400-E053-F662850A776C","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520033E-D0DB-2151-E053-F662850A12D0","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Obesity","valueDescription":"Obesity","ValueMeaning":{"publicId":"2566203","version":"1","preferredName":"Obesity","longName":"2566203","preferredDefinition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obesity","conceptCode":"C3283","definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFA8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520033E-D0E6-2151-E053-F662850A12D0","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"6060199","version":"1","preferredName":"Specify Other","longName":"6060199","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-2332-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405A6BF-1926-4F72-E053-F662850AD4A7","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","deletedIndicator":"No"},{"value":"Alcoholic liver disease","valueDescription":"Alcoholic Liver Disease","ValueMeaning":{"publicId":"3210771","version":"1","preferredName":"Alcoholic Liver Disease","longName":"3210771","preferredDefinition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alcoholic Liver Disease","conceptCode":"C34783","definition":"A disorder caused by damage to the liver parenchyma due to alcohol consumption. It may present with an acute onset or follow a chronic course, leading to cirrhosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9D1A-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7405A6BF-1931-4F72-E053-F662850AD4A7","beginDate":"2018-08-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-22","modifiedBy":"ONEDATA","dateModified":"2018-08-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3171837","version":"1","preferredName":"Primary Risk Factor Name","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations.:The words or language units by which a thing is known.","longName":"C25251:C17103:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk Factor","conceptCode":"C17103","definition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-010F-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"ONEDATA","dateModified":"2010-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CE40-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"COOPERM","dateModified":"2018-09-05","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 12/2010 sw Versioned VD to increase max length and add PVs per request by K.Diconstanzo. mc 12/3/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"6403794","version":"1","longName":"HCC and Bile Duct Cancer","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient History of primary ri","type":"Preferred Question Text","description":"Patient History of primary risk factor(s) for bile duct cancer","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"751FDBF0-875C-2149-E053-F662850AF0CC","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}